- Home
- ALDX vs SOPH Comparison
ALDX vs SOPH Comparison
Compare ALDX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- SOPH
- Stock Information
- Founded
- ALDX 2004
- SOPH 2011
- Country
- ALDX United States
- SOPH Switzerland
- Employees
- ALDX N/A
- SOPH N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALDX Health Care
- SOPH Health Care
- Exchange
- ALDX Nasdaq
- SOPH Nasdaq
- Market Cap
- ALDX 270.7M
- SOPH 219.8M
- IPO Year
- ALDX 2014
- SOPH 2021
- Fundamental
- Price
- ALDX $4.81
- SOPH $3.16
- Analyst Decision
- ALDX Strong Buy
- SOPH Buy
- Analyst Count
- ALDX 2
- SOPH 1
- Target Price
- ALDX $9.50
- SOPH $7.00
- AVG Volume (30 Days)
- ALDX 1.2M
- SOPH 37.6K
- Earning Date
- ALDX 08-12-2025
- SOPH 08-05-2025
- Dividend Yield
- ALDX N/A
- SOPH N/A
- EPS Growth
- ALDX N/A
- SOPH N/A
- EPS
- ALDX N/A
- SOPH N/A
- Revenue
- ALDX N/A
- SOPH $67,173,000.00
- Revenue This Year
- ALDX N/A
- SOPH $16.13
- Revenue Next Year
- ALDX $29.89
- SOPH $23.80
- P/E Ratio
- ALDX N/A
- SOPH N/A
- Revenue Growth
- ALDX N/A
- SOPH 4.66
- 52 Week Low
- ALDX $1.14
- SOPH $2.58
- 52 Week High
- ALDX $7.20
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- ALDX 53.97
- SOPH 42.82
- Support Level
- ALDX $5.21
- SOPH $3.36
- Resistance Level
- ALDX $5.35
- SOPH $3.75
- Average True Range (ATR)
- ALDX 0.33
- SOPH 0.21
- MACD
- ALDX -0.12
- SOPH -0.07
- Stochastic Oscillator
- ALDX 40.70
- SOPH 9.09
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.